Why Cathie Wood Sold Key ARK Invest Holdings This Quarter

Quick Answer

Cathie Wood sold key ARK Invest holdings this quarter as part of routine portfolio rebalancing, profit-taking after price surges, and reallocation into other innovative assets like SpaceX. Specific sales include $3 million of TSMC, $11.5 million of Amazon, and $2 million of SoFi on June 15, 2026, alongside earlier cuts to AMD, CRISPR Therapeutics, and other positions.

These moves reflect Wood's active management strategy—trimming winners and raising cash for new opportunities—rather than a bearish outlook on these companies. Investors should view these sales as tactical adjustments within a high-conviction, innovation-focused portfolio.

Key Facts

• On June 15, 2026, ARK Invest sold $11.5 million of Amazon (AMZN), $3 million of TSMC (TSM), $2.2 million of BMNR, $2 million of SoFi (SOFI), and $1.4 million of NTRA.
• On June 11, 2026, Wood sold $1.4 million of CERS and $5.1 million of RXRX.
• In Q3 2024, ARK sold 3.6% of its CRISPR Therapeutics AG shares (-280,000 shares) at an average closing price of $50.74.
• In Q2 2024, ARK sold 4.6% of CRISPR shares (-378,000 shares).
• On April 24, 2024, Wood sold $75 million worth of AMD stock (215,643 shares) after a rally.
• In May 2024, ARK Invest sold roughly $163 million worth of various stocks in one day, with proceeds reportedly funding purchases of SpaceX stock.
• Over the 10 years ending in 2024, the Ark Innovation ETF wiped out $7 billion in investor wealth, according to Morningstar analysis.
• ARK Invest's total portfolio value is approximately $14.9 billion, invested in 604 stocks.
• Q4 2024 saw a ~30% reduction in certain positions at prices between $36.46 and $82.38, followed by a ~20% reduction in the next quarter.

Background and Context

Cathie Wood is the CEO and Chief Investment Officer of ARK Invest, an asset management firm known for its concentrated bets on disruptive innovation across sectors like genomics, autonomous driving, fintech, and artificial intelligence. Her flagship ARKK ETF (ARK Innovation ETF) has attracted both fervent followers and sharp critics due to its high volatility and dramatic performance swings.

Wood's investment philosophy centers on identifying companies that she believes will benefit from exponential technological change. She frequently cites a forecast that innovation could be worth $220 trillion by 2030, a figure she has used to justify high valuations and long holding periods.

This approach has led to massive inflows during bull markets and steep drawdowns during downturns. The context for the sales in this quarter is critical.

ARK Invest operates a highly active trading desk, publishing daily trade reports. Wood is known for buying on dips and selling into strength, a pattern visible across multiple holdings.

The sales are not necessarily signals of lost conviction; they often fund purchases of other innovation stocks or private placements like SpaceX, which ARK has been accumulating. The Morningstar finding that ARKK wiped out $7 billion in investor wealth over the 10 years ending 2024 underscores the risks.

This figure reflects not just share price declines but also the timing of investor flows—many bought at peaks. It highlights that Wood's strategy works best for patient investors who can tolerate extreme drawdowns, but has been punishing for those who entered late or exited early.

Understanding the mechanics of ARK's trades is also important. ARK Invest manages multiple ETFs (ARKK, ARKW, ARKG, ARKQ, ARKF) that often trade the same stocks.

When Wood sells a position in one fund, it may be offset by buying in another. The daily trade reports from sources like mymoneywood.com and cathiesark.com show these granular movements.

The June 15, 2026 sales, for example, were 100% sells across ARKK and ARKW ETFs, indicating a coordinated reduction.

Detailed Explanation

The June 2026 Sales A Snapshot

The most recent data shows a flurry of selling on June 15, 2026, and June 11, 2026. Here is the breakdown:

June 15, 2026:

• Amazon (AMZN): $11.5 million sold. This is a significant reduction, representing 100% of the trade in ARKK and ARKW ETFs. Amazon is one of ARK's largest holdings, so trimming here frees up substantial capital.
• TSMC (TSM): $3 million sold. Taiwan Semiconductor Manufacturing is a core semiconductor player. The sale might reflect profit-taking after TSMC's strong run driven by AI chip demand.
• BMNR: $2.2 million sold. This ticker likely refers to a smaller biotech or innovation stock. Without detailed filings, the specific identity is unclear, but it fits ARK's pattern of trimming smaller positions.
• SoFi (SOFI): $2 million sold. SoFi is a fintech company ARK has held for years. The sale could be rebalancing after recent gains or to fund other fintech bets.
• NTRA: $1.4 million sold. Natera is a genetic testing company in ARK's genomics portfolio. This reduction aligns with Wood's pattern of taking profits on genomics stocks after rallies.

June 11, 2026:

• RXRX: $5.1 million sold. Recursion Pharmaceuticals is an AI-driven drug discovery company. This is a notable sale given ARK's enthusiasm for AI in healthcare.
• CERS: $1.4 million sold. Cerus Corporation is a blood safety technology company. This smaller sell likely represents portfolio trimming.

These sales total approximately $26.6 million in a single week. While significant, it is modest compared to ARK's $14.9 billion portfolio.

The sales are not panic-driven; they are methodical reductions.

The AMD and CRISPR Sales Historical Context

Looking back to 2024 provides a clearer pattern:

AMD (April 24, 2024): Wood sold $75 million of AMD stock after the semiconductor company's shares surged. AMD had been a top holding for ARK, but Wood had been trimming since 2022.

The sale of 215,643 shares was timed near a high, demonstrating her strategy of selling into strength. AMD's rally was fueled by AI chip demand, making it a classic "sell the winner" move.

CRISPR Therapeutics (Q2 and Q3 2024): ARK sold 4.6% of its CRISPR position in Q2 2024 (378,000 shares) and another 3.6% in Q3 2024 (280,000 shares). The average closing price during Q3 was $50.74, with a range of $44.62 to $62.75.

CRISPR is a gene-editing pioneer, a high-risk/high-reward play. Wood has been a long-term bull, but these trims suggest either profit-taking after the stock's recovery from lows or rebalancing into other genomics plays like Beam Therapeutics or Intellia.

The $163 Million Clean House Day (May 2024)

On a single day in May 2024, ARK Invest sold roughly $163 million worth of stock. This was not a random event; it was a deliberate rebalancing.

Reports indicate that the proceeds funded purchases of SpaceX stock. SpaceX is a private company, not publicly traded, so ARK's ability to buy it comes through secondary markets or special purpose vehicles.

This trade exemplifies Wood's willingness to shift from liquid public stocks into illiquid private ones if she sees higher innovation potential.

Why Sell? The Strategic Rationale

Cathie Wood's selling falls into four categories:

1. Profit-Taking and Rebalancing: When a stock doubles or triples, it can become an outsized portion of a portfolio.

Wood trims winners to lock in gains and maintain target weights. This is standard portfolio management, not a bearish signal.

2. Raising Cash for New Ideas: ARK is constantly searching for the next disruptive company.

If Wood sees a compelling opportunity—like SpaceX, or a beaten-down genomics stock—she sells existing positions to raise cash. The $163 million sale in May 2024 is a clear example.

3. Tax-Loss Harvesting: While not always the primary motive, selling losing positions to offset gains can be a factor.

ARK has had many stocks decline sharply, so selling them at a loss reduces tax liabilities. 4.

Reducing Exposure to Mature Companies: Amazon, TSMC, and AMD are large, established companies. Wood's thesis is that innovation will come from smaller, more agile firms.

Trimming these giants may reflect a shift toward earlier-stage disruptors.

The Performance Track Record and Its Implications

The Morningstar analysis that ARKK wiped out $7 billion in investor wealth is a sobering data point. It does not mean the fund lost $7 billion in absolute terms; it means investor timing was so poor that the net result of all money flowing in and out was a $7 billion loss relative to what investors would have earned in a passive index.

This pattern is common with high-volatility funds: investors buy after strong performance and sell after declines, locking in losses. For context, ARKK had a spectacular 2020 (up ~150%) and a brutal 2021-2022 (down ~75%).

The 2023-2024 recovery was partial. The $7 billion figure captures the pain of investors who bought at the peak.

It also explains why Wood's selling decisions are scrutinized—if she sells too early, she might miss further gains; if she sells too late, she locks in losses for her remaining holders.

The Portfolio Composition as of Mid-2026

With a total portfolio value of $14.9 billion spread across 604 stocks, ARK is highly diversified by number of holdings, but concentrated by weight. The top 10 positions typically account for 40-50% of assets.

Key themes include:

• Genomics: CRISPR Therapeutics, Intellia, Beam, Natera (NTRA)
• Fintech: SoFi, Coinbase, Block (SQ)
• Autonomous Driving: Tesla (still a top holding), Zoox (private)
• AI and Semiconductors: AMD, TSMC, UiPath
• Digital Health: Recursion Pharmaceuticals (RXRX), Cerus (CERS)
• E-commerce: Amazon (AMZN)

The June 2026 sales touch multiple themes, suggesting a broad-based rebalancing rather than a sector-specific bet.

Common Questions and Misconceptions

1. "Cathie Wood selling means she has lost faith in the stock."

This is the most common misconception. Wood has repeatedly stated that she sells winners to buy what she believes are bigger winners.

She held Tesla through massive drawdowns and sold small amounts periodically. Trimming Amazon does not mean she thinks Amazon is doomed; it means she sees a better risk/reward in other innovation stocks.

The sales are often quite small relative to the total position size.

2. "ARK's selling is a signal to retail investors to sell too."

Retail investors have different time horizons, risk tolerances, and tax situations. Wood manages a fund with daily inflows and outflows; she must sell to meet redemptions or to rebalance.

Individual investors should base decisions on their own analysis, not on a fund manager's daily trades. Copying ARK's trades blindly can lead to poor outcomes, especially if one lacks the conviction to hold through downturns.

3. "The $7 billion loss proves Cathie Wood is a bad investor."

This statistic is often misunderstood. The $7 billion figure is about investor behavior, not fund performance.

The fund itself had a cumulative gain over the 10-year period, but because investors bought high and sold low, they lost money. This pattern is common with high-volatility funds.

The fund's long-term returns, while volatile, have been positive if held through the full period. The criticism is valid about investor education, not necessarily about Wood's stock-picking ability.

4. "Selling $163 million in one day means ARK is in trouble."

No. The $163 million sale in May 2024 was explicitly linked to funding a SpaceX purchase.

SpaceX is not publicly traded, so ARK cannot easily buy it on the open market. They must sell liquid stocks to raise cash for private placements.

This is a sign of active management, not distress. ARK's daily trade reports show similar large sales and purchases regularly.

5. "ARK's sales are always at the worst possible time."

Wood has been criticized for selling Tesla before its 2020 rally and for buying Zoom at the peak. However, she also sold AMD near its 2024 highs and trimmed CRISPR before a subsequent decline.

The reality is mixed. No manager times every move perfectly.

Wood's strategy is to hold for five years or more, so she is willing to accept short-term underperformance for long-term gains. The sales in June 2026 may look smart or foolish in hindsight, but they are part of a consistent process.

What to Watch For

Monitor ARK's 13F Filings

The most reliable way to track ARK's portfolio is through its quarterly 13F filing with the SEC. These filings show all U.S.

stock holdings as of the end of each quarter. They are released 45 days after quarter-end.

The Q1 2026 filing, for example, reveals the full portfolio snapshot. Investors can compare 13F data to daily trade reports to see how much positions have changed.

Pay Attention to the "Why"

When Wood sells a large position like Amazon, look for public statements or interviews explaining the rationale. She often discusses trades on CNBC or in ARK's research blog.

Understanding the thesis behind the sale—whether it is profit-taking, rebalancing, or a shift in conviction—is more useful than the sale itself.

Watch for Sector Rotation

The June 2026 sales hit fintech (SoFi), genomics (NTRA, RXRX), and semiconductors (TSM). If ARK continues selling across these themes, it may indicate a broader shift in innovation focus.

Conversely, if she buys more of a beaten-down sector like genomics afterward, it confirms the "sell high, buy low" pattern.

Track the SpaceX Position

SpaceX has been a recurring purchase for ARK. Since it is private, its value is less transparent.

If ARK continues selling public stocks to fund SpaceX buys, it suggests Wood's conviction in space innovation is high. Investors should watch for any updates on SpaceX's valuation or IPO plans.

Beware of Copying Trades Without Context

Retail investors often try to mimic ARK's daily trades via apps like M1 Finance or Robinhood. This is dangerous because:

• Trades are reported with a one-day delay.
• ARK may have different tax implications.
• ARK's size allows it to enter/exit positions without moving the market; retail investors cannot.
• Wood holds positions for years; copying a single day's sell may miss the bigger picture.

Frequently Asked Questions

Why did Cathie Wood sell Amazon stock in June 2026?

On June 15, 2026, ARK Invest sold $11.5 million of Amazon across its ARKK and ARKW ETFs. This is likely a profit-taking or rebalancing move.

Amazon has been a strong performer, and Wood may be reallocating capital into smaller innovation stocks or private placements like SpaceX. The sale represents a small fraction of ARK's total Amazon position.

Is Cathie Wood bearish on semiconductors?

Not necessarily. She sold $75 million of AMD in April 2024 and $3 million of TSMC in June 2026, but ARK still holds significant positions in both.

The sales appear to be tactical—taking profits after strong runs—rather than a fundamental rejection of the sector. Wood has been bullish on AI-driven chip demand long-term, as reflected in her continued holdings of AMD and TSMC.

How much money has ARKK lost for investors?

According to a Morningstar analysis covering the 10 years ending 2024, the Ark Innovation ETF wiped out $7 billion in investor wealth. This figure accounts for the timing of investor cash flows—meaning investors collectively lost $7 billion relative to what they would have earned in a passive index.

The fund itself had positive cumulative returns over that period, but poor investor timing (buying high, selling low) caused net losses.

Should I sell my stocks when Cathie Wood sells?

No. Cathie Wood's trades are based on her fund's specific strategy, tax situation, and liquidity needs.

Individual investors should make decisions based on their own risk tolerance, time horizon, and research. Copying a single day's sell order without understanding the context can lead to poor outcomes.

If you own a stock and believe in its long-term prospects, a fund manager's trimming should not trigger an automatic sell.

How can I track Cathie Wood's daily trades?

ARK Invest publishes daily trade reports on its official website. Third-party trackers like cathiesark.com and mymoneywood.com aggregate these trades and provide analysis.

Social media accounts like @ArkkDaily on X also post daily updates. For the most accurate and timely information, visit ARK Invest's official website and check the "Daily Trades" section.

Reference Notes

Information in this article is based on publicly available sources. Some details may change over time.

Verify with official sources before acting.